Pharmaceutical industry support for continuing medical education: Is it time to disengage?

Journal of Paediatrics and Child Health

Volumn 47, Issue 10, 2011, Pages 690-692

  Kerridge, Ian ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

conflict of interest; ethics; medical education; pharmaceutical industry

Indexed keywords

ADVERSE OUTCOME; CONTINUING EDUCATION; DRUG COST; DRUG INDUSTRY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MARKETING; MEDICAL EDUCATION; MEDICAL PROFESSION; MEDICAL RESEARCH; MEDICAL SCHOOL; MEDICAL STUDENT; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; VOCATIONAL EDUCATION;

AUSTRALIA; CONFLICT OF INTEREST; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; HUMANS;

EID: 80054804092     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2011.02191.x     Document Type: Short Survey

References (31)

1. Angell M,. The Truth about the Drug Companies: How They Deceive Us and What to Do about It. New York: Random House, 2004.
2. Henry DA, Doran E, Kerridge IH, Hill SR, McNeill PM, Day RO,. Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry. Arch. Intern. Med. 2005; 165: 2493-6. (Pubitemid 41720011)
3. Brennan TA, Rothman D, Blank L, et al,. Health industry practices that create conflicts of interest-a policy proposal for academic medical centers. JAMA 2006; 295: 429-33. (Pubitemid 43144979)
4. Komesaroff P,. Ethical issues associated with gifts provided to physicians by the pharmaceutical industry. Intern. Med. J. 2010; 40: 321-2.
5. O'Connell C,. Pressure mounts to strip industry funding from continuing medical education programs. CMAJ 2010; 182: E775-6.
6. Gagnon MA, Lexchin J,. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008; 5: e1. doi:10.1371/journal.pmed.0050001 (Pubitemid 351216978)
7. Wazana A,. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373-80. (Pubitemid 30051756)
8. Norris P, Herxheimer A, Lexchin J, Mansfield P,. Drug Promotion: What We Know, What Have We Yet to Learn. Geneva: World Health Organization and Health Action International, 2005.
9. Carmody DM, Mansfield PR,. What do medical students think about pharmaceutical promotion? Australian Med. Student J. 2010; 1: 54-7.
10. Financial Relationships with Industry in Continuing Medical Education. Report of the Council on Ethical and Judicial Affairs. 2010. Available from: http://www.ama-assn.org/ama1/pub/upload/mm/475/ceja01a09.pdf [accessed 1 June 2011].
11. Brody H,. Clarifying conflict of interest. Am. J. Bioeth. 2011; 11: 23-8.
12. Dyer C,. New code requires doctors to disclose all links with drug industry. BMJ 2011; 342: d2188.
13. Association of American Medical Colleges. Industry Funding of Medical Education. Report of an AAMC Task Force. Washington, DC: AAMC, 2008.
14. Institute of Medicine. Redesigning Continuing Education in the Health Professions. Washington, DC: National Academies Press, 2010.
15. Fletcher SW,. Chairman's summary of the conference: continuing education in the health professions: improving healthcare through lifelong learning. J. Contin. Educ. Nurs. 2008; 39: 112-8.
16. Lo B, Field MJ, eds. Institute of Medicine: Conflict of Interest in Medical Research, Education and Practice. Washington, DC: National Academies Press, 2009.
17. Ozretic A, Collier R,. Medical schools continue to tighten noose on faculty with conflicts of interest. CMAJ 2010; 182: E161-2.
18. Rothman DJ, McDonald WJ, Berkowitz CD, et al,. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 2009; 301: 1367-72.
19. Avorn J, Choudhry NK,. Funding for medical education: maintaining a healthy separation from industry. Circulation 2010; 121: 2228-34.
20. Brody H,. Hooked: Ethics, the Medical Profession and the Pharmaceutical Industry. Lanham, MD: Rowman and Littlefield, 2007.
21. Rodwin MA,. Drug advertising, continuing medical education, and physicians prescribing: a historical review and reform proposal. J. Law Med. Ethics 2010; 38: 807-15.
22. Ryan C, Walter G, Robertson M,. College activities and the ethics of advertising. Australas. Psychiatry 2010; 18: 101-5.
23. Attending conferences. under the influence. Nat. Med. 2011; 17: 640-1.
24. Moynihan R,. Drug company sponsorship of education could be replaced at a fraction of its cost. BMJ 2003; 326: 1163.
25. Mueller PS, Hook CC, Litin SC,. Physician preferences and attitudes regarding industry support of CME programs. Am. J. Med. 2007; 120: 281-5. (Pubitemid 46341175)
26. Rutledge P, Crookes D, McKinstry B, Maxwell SR,. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Pharmacoepidemiol. Drug Saf. 2003; 12: 663-7. (Pubitemid 38028780)
27. Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB,. Clinician attitudes about commercial sponsorship of continuing medical education. Arch. Intern. Med. 2011; 171: 840-6.
28. Kuehn BM,. Successes, challenges emerge from efforts to shift away from industry-funded CME. JAMA 2010; 304: 729-31.
29. Brody H,. Drug detailers, professionalism and prudence. Am. J. Bioeth. 2010; 10: 9-10.
30. Lo B,. Conflict of interest policies: an opportunity for the medical profession to take the lead. Acad. Med. 2010; 85: 9-11.
31. Morris L, Taitsman JK,. The agenda for continuing medical education-limiting industry's influence. N. Engl. J. Med. 2008; 361: 2478-82.